HOPE Therapeutics™, Inc. ("HOPE"), a medical and technology driven company, and a wholly-owned subsidiary of NRx ...

NRX Pharmaceuticals shares are moving higher on Tuesday after it invested $27 million in its subsidiary HOPE Therapeutics.

Hope Therapeutics, a wholly-owned subsidiary of NRx Pharmaceuticals (NRXP), announced engagement of BTIG, a leading global financial services ...

NRx Pharmaceuticals (NRXP) announced that it has entered into a binding agreement for a registered direct offering of its common stock with ...

Ahead of the German elections, Elon Musk has thrown his weight behind AfD, the far-right party threatening to upend the nation’s politics. And Trump’s new regime poses huge challenges for defence, ...

The Company has recently announced execution of an agreement for $27 million in funding for HOPE Clinic Acquisition. Upon closing of the first tranch ...

NRXP has entered a transformative partnership with Alvogen Pharmaceuticals for the development and marketing of NRX-101. Beyond its mental health applications, NRX-101 shows promise as a non-opioid ...

MIAMI - NRx Pharmaceuticals, Inc. (NASDAQ:NRXP), a clinical-stage biopharmaceutical company with a current market capitalization of $34.37 million, has announced a financing agreement to support ...

Shares of NRx Pharmaceuticals Inc. surged nearly 25% on Tuesday, its best session in almost three weeks, drawing heavy ...

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP), a Delaware-based pharmaceutical company with a market capitalization of $61.63 million, announced the immediate resignation of Janet Rehnquist from its ...

NRx Pharmaceuticals, Inc. recently disclosed its entry into a binding term sheet defining the terms of a significant share purchase agreement (SPA). The agreement involves NRx Pharmaceuticals ...